Stay updated on IPI-145 Plus FCR in CLL Clinical Trial

Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Updates shown (2026-01, 2026-01-27, 2026-02-13) appear to be administrative metadata changes to the study record, such as new update timestamps, and do not modify core content like eligibility criteria, endpoints, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-18T03:51:54.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and Revision: v3.4.1 was removed, along with deletion of the funding-status notice, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:24:09.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A site-wide Notice about government funding and NIH Clinical Center operations was added, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:01:23.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page adds a glossary display and new metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted) with a new Revision: v3.4.0, replacing older metadata items (Last Update Posted (Estimated), No FEAR Act Data, Revision: v3.3.4).
    Difference
    0.3%
    Check dated 2026-01-27T21:21:03.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page deleted the Study Protocol and Statistical Analysis Plan PDF, the Study Documents section, investigators and institution names, IPD sharing details, and related drug and MeSH term metadata.
    Difference
    19%
    Check dated 2026-01-20T16:17:55.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    Added a dedicated Locations section with Massachusetts listed as a study site, and updated the page revision to v3.3.3. The old 'Massachusetts Locations' label was removed and the 'HHS Vulnerability Disclosure' footer link was also removed.
    Difference
    0.2%
    Check dated 2025-12-22T22:50:54.000Z thumbnail image

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.